The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure

Journal of the American College of Cardiology

Volumn 46, Issue 5, 2005, Pages 845-849

  Shah, Keyur B ^a   Rao, Krishnamurti ^a   Sawyer, Robert ^a   Gottlieb, Stephen S ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; POTASSIUM; SPIRONOLACTONE;

CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG MONITORING; DRUG SAFETY; FOLLOW UP; HUMAN; HYPERKALEMIA; KIDNEY FAILURE; KIDNEY FUNCTION TEST; LABORATORY TEST; MEDICAL ASSESSMENT; MEDICAL RECORD; PATIENT MONITORING; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PUBLICATION; REVIEW;

EID: 24044466543     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.06.010     Document Type: Article

References (8)

1. B. Pitt, F. Zannad, W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
2. H. Ikram, M.W. Webster, M.G. Nicholls, G.R. Lewis, A.M. Richards, I.G. Crozier Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure Aust N Z J Med 16 1986 61 63
3. A.A. van Vliet, A.M. Donker, J.P. Nauta, F.W. Verheugt Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor Am J Cardiol 71 1993 21 28A
4. D.N. Juurlink, M.M. Mamdani, D.S. Lee Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 6 2004 543 551
5. B. Bozkurt, I. Agoston, A.A. Knowlton Complications of inappropriate use of spironolactone in heart failure when an old medicine spirals out of new guidelines J Am Coll Cardiol 41 2003 211 214
6. H.T. Stelfox, S.B. Ahmed, J. Fiskio, D.W. Bates Monitoring amiodarone's toxicities recommendations, evidence, and clinical practice Clin Pharmacol Ther 75 2004 110 122
7. B. Pitt, W. Remme, F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
8. A.K. Jha, J.B. Perlin, K.W. Kizer, R.A. Dudley Effect of the transformation of the Veterans Affairs health care system on the quality of care N Engl J Med 348 2003 2218 2227